{
  "version": "2025-11-01",
  "eiProfiles": [
    { "key": "difficult_hcp", "label": "Difficult HCP" },
    { "key": "busy_hcp", "label": "Busy HCP" },
    { "key": "engaged_hcp", "label": "Highly Engaged HCP" },
    { "key": "indifferent_hcp", "label": "Indifferent HCP" }
  ],
  "eiFeatures": [
    { "key": "empathy", "label": "Empathy" },
    { "key": "objection", "label": "Objection Handling" },
    { "key": "clarity", "label": "Clarity & Confidence" },
    { "key": "compliance", "label": "Accuracy & Compliance" },
    { "key": "discovery", "label": "Discovery" }
  ],
  "scenarios": [
    {
      "id": "hiv_im_decile3_prep_lowshare",
      "mode": "sales-simulation",
      "therapeuticArea": "HIV",
      "persona": "Internal Medicine MD",
      "title": "Low Descovy share with missed PrEP opportunity",
      "brief": "Decile 3 IM prescriber underutilizes PrEP despite steady STI testing in young MSM; inconsistent quarterly labs and follow-ups.",
      "goals": [
        "Surface candidate volume from STI testing",
        "Address renal safety within label guidance",
        "Standardize quarterly labs and follow-ups"
      ],
      "guardrails": [
        "No off-label claims",
        "Label-consistent renal safety language",
        "No promises of outcomes"
      ]
    },
    {
      "id": "hiv_np_decile10_highshare_access",
      "mode": "sales-simulation",
      "therapeuticArea": "HIV",
      "persona": "Nurse Practitioner",
      "title": "High Descovy share but access and staffing barriers",
      "brief": "Decile 10 NP with strong share; PA workload and workflow friction limit breadth of appropriate prescribing.",
      "goals": [
        "Implement twice-weekly PA batching with pharmacy partner",
        "Run benefits checks upstream of visits",
        "Reassess appropriate TDF users with unrestricted coverage"
      ],
      "guardrails": [
        "Stay on-label",
        "Do not discuss pricing guarantees",
        "Avoid comparative efficacy claims"
      ]
    },
    {
      "id": "hiv_pa_decile9_treat_switch_slowdown",
      "mode": "sales-simulation",
      "therapeuticArea": "HIV",
      "persona": "Physician Assistant",
      "title": "Slowing Biktarvy switches in stable patients",
      "brief": "Switch velocity fell to 1–2 in 13 weeks; perception that most patients are optimized.",
      "goals": [
        "Define labeled criteria for considering a switch",
        "Identify candidates via labs/adherence flags",
        "Pilot quarterly optimization sessions"
      ],
      "guardrails": [
        "No outcomes promises",
        "No off-label discussion",
        "Patient-specific risk/benefit framing"
      ]
    },
    {
      "id": "hiv_np_decile5_cab_growth",
      "mode": "sales-simulation",
      "therapeuticArea": "HIV",
      "persona": "Nurse Practitioner",
      "title": "Favoring CAB/RPV without uniform screening",
      "brief": "CAB share growing; requests often honored without systematic adherence/resistance evaluation.",
      "goals": [
        "Adopt eligibility and resistance-history checklist",
        "Implement missed-dose mitigation plan",
        "Use a shared injection calendar workflow"
      ],
      "guardrails": [
        "Only labeled indications",
        "No comparative superiority statements",
        "Avoid outcomes guarantees"
      ]
    },
    {
      "id": "hiv_im_decile4_prep_apretude_gap",
      "mode": "sales-simulation",
      "therapeuticArea": "HIV",
      "persona": "Internal Medicine MD",
      "title": "Low Apretude vs TDF/FTC and Descovy",
      "brief": "PrEP mix skewed to orals; PA backlog; missing standing lab protocol; adherence misconceptions on long-acting.",
      "goals": [
        "Clarify initiation and follow-up cadence",
        "Stand up PA batching and lab/injection calendar",
        "Target adherence-challenged candidates appropriately"
      ],
      "guardrails": [
        "No efficacy promises",
        "Stay strictly on-label",
        "Direct AE/PQC appropriately"
      ]
    },
    {
      "id": "hiv_np_decile9_prep_ops_cap",
      "mode": "sales-simulation",
      "therapeuticArea": "HIV",
      "persona": "Nurse Practitioner",
      "title": "Strong PrEP program but operationally capped",
      "brief": "High demand; PA burden caps TAF/Apretude; ad-hoc pharmacy engagement.",
      "goals": [
        "Pharmacy-tech supported PA batching",
        "Monthly long-acting start day",
        "Default appropriate naive high-risk candidates"
      ],
      "guardrails": [
        "No coverage guarantees",
        "On-label only",
        "Respect site protocols"
      ]
    },
    {
      "id": "hiv_pa_decile7_treat_switch_day",
      "mode": "sales-simulation",
      "therapeuticArea": "HIV",
      "persona": "Physician Assistant",
      "title": "Treatment optimization day for switches",
      "brief": "Hospital-affiliated ID clinic; few recent switches; CAB/RPV interest among adherent younger patients.",
      "goals": [
        "Define CAB/RPV candidacy criteria",
        "Establish counseling script and consent flow",
        "Track suppression and missed-dose metrics"
      ],
      "guardrails": [
        "Label-only use",
        "No outcomes guarantees",
        "Respect institutional policies"
      ]
    },
    {
      "id": "onc_md_decile10_io_adc_pathways",
      "mode": "product-knowledge",
      "therapeuticArea": "Oncology",
      "persona": "Medical Oncologist",
      "title": "IO-backbone heavy; ADC toxicity bandwidth",
      "brief": "Solid-tumor center evaluating ADCs; cost/response and chair time scrutinized; toxicity bandwidth constrained.",
      "goals": [
        "Align biomarker-defined subset and evidence category",
        "Outline toxicity mitigation workflow",
        "Advance to tumor board and order sets"
      ],
      "guardrails": [
        "Cite labeled sources or NCCN categories",
        "No off-label promotion",
        "Avoid cost-effectiveness claims"
      ]
    },
    {
      "id": "onc_np_decile6_pathway_ops",
      "mode": "sales-simulation",
      "therapeuticArea": "Oncology",
      "persona": "Oncology NP",
      "title": "Pathway-driven care with staffing constraints",
      "brief": "Community infusion; conservative IO use; AE clinics short-staffed; inconsistent education packets.",
      "goals": [
        "Adopt NP-led education templates",
        "Add AE one-pager to pathway handouts",
        "Implement toxicity call-tree"
      ],
      "guardrails": [
        "Education is non-promotional",
        "Stay on-label",
        "No outcomes guarantees"
      ]
    },
    {
      "id": "onc_pa_decile7_gu_oral_onc_tminus7",
      "mode": "sales-simulation",
      "therapeuticArea": "Oncology",
      "persona": "Oncology PA (GU)",
      "title": "Oral oncolytic onboarding at T-7",
      "brief": "Hub forms and day-25–30 refill gaps due to late onboarding.",
      "goals": [
        "Enroll hub and benefits check at T-7",
        "Schedule day-10 toxicity tele-visit",
        "Implement refill safeguard checklist"
      ],
      "guardrails": [
        "Operational guidance only",
        "No treatment advice to patients",
        "On-label education"
      ]
    },
    {
      "id": "vac_id_decile8_adult_flu_playbook",
      "mode": "sales-simulation",
      "therapeuticArea": "Vaccines",
      "persona": "Infectious Disease Specialist",
      "title": "Adult flu program underperforming",
      "brief": "Late clinic launches; weak reminder-recall; coverage fell in 65+.",
      "goals": [
        "Pre-book age-appropriate inventory",
        "Launch early clinics with SMS reminders",
        "Enable standing orders in LTC"
      ],
      "guardrails": [
        "Use ACIP-aligned statements",
        "No outcomes guarantees",
        "No payer promises"
      ]
    },
    {
      "id": "vac_np_decile5_primary_care_capture",
      "mode": "sales-simulation",
      "therapeuticArea": "Vaccines",
      "persona": "Family Medicine NP",
      "title": "Primary care capture with fragmented workflows",
      "brief": "Adequate storage but VIS misses; ad-hoc Saturday clinics.",
      "goals": [
        "Adopt standing orders and huddle checklists",
        "Fix weekend clinic cadence",
        "Standardize VIS documentation"
      ],
      "guardrails": [
        "Follow ACIP and VIS requirements",
        "No outcomes guarantees",
        "On-label language"
      ]
    },
    {
      "id": "vac_pa_decile6_oh_campus_outreach",
      "mode": "sales-simulation",
      "therapeuticArea": "Vaccines",
      "persona": "Physician Assistant (Occupational Health)",
      "title": "Employer and college outreach alignment",
      "brief": "Student uptake low; inventory turns slow due to late campus events.",
      "goals": [
        "Schedule campus pop-ups at orientation and midterms",
        "Pre-register students for throughput",
        "Rebalance excess inventory by week 6"
      ],
      "guardrails": [
        "No coverage guarantees",
        "On-label only",
        "Respect institutional policies"
      ]
    },
    {
      "id": "covid_pulm_md_decile9_antiviral_ddi_path",
      "mode": "product-knowledge",
      "therapeuticArea": "COVID-19",
      "persona": "Pulmonologist",
      "title": "Outpatient antivirals under-utilized",
      "brief": "High-risk COPD/ILD; Paxlovid first-line; 3-day remdesivir limited by capacity; DDI triage slows prescribing.",
      "goals": [
        "Implement rapid DDI screening protocol",
        "Secure standing infusion slots where eligible",
        "Track initiation within 48 hours"
      ],
      "guardrails": [
        "Cite labeled information only",
        "No outcomes guarantees",
        "No comparative claims"
      ]
    },
    {
      "id": "covid_pulm_np_decile6_postcovid_adherence",
      "mode": "sales-simulation",
      "therapeuticArea": "COVID-19",
      "persona": "Pulmonary NP",
      "title": "Post-COVID clinic adherence issues",
      "brief": "Day 4–5 presentations; callbacks delay start; rebound education variable.",
      "goals": [
        "Use same-day eRx template",
        "Provide rebound education one-pager",
        "Route day-2 positives to NP tele-start"
      ],
      "guardrails": [
        "On-label education",
        "No outcomes guarantees",
        "Avoid comparative statements"
      ]
    },
    {
      "id": "covid_pulm_pa_decile5_hospital_at_home",
      "mode": "sales-simulation",
      "therapeuticArea": "COVID-19",
      "persona": "Pulmonary PA",
      "title": "Hospital-at-home linkage for antivirals",
      "brief": "Discharges qualify for outpatient therapy but lack transport for IV remdesivir; home-infusion underused.",
      "goals": [
        "Default home-infusion referral when indicated",
        "Embed discharge checklist and referral workflow",
        "Track 7-day readmissions"
      ],
      "guardrails": [
        "No outcomes guarantees",
        "On-label use only",
        "Respect discharge policies"
      ]
    },
    {
      "id": "cv_card_md_decile10_hf_gdmt_uptake",
      "mode": "sales-simulation",
      "therapeuticArea": "Cardiovascular",
      "persona": "Cardiologist",
      "title": "HFrEF clinic with uneven GDMT adoption",
      "brief": "Entresto uptake 62% of eligible HFrEF; SGLT2 at 38%; fellows handle PAs; day-30 refill gaps.",
      "goals": [
        "Adopt discharge GDMT checklist with accountable owners",
        "Enroll copay support via pharmacy tech",
        "Raise SGLT2 by 10pp and halve 30-day gaps"
      ],
      "guardrails": [
        "No outcomes guarantees",
        "On-label statements only",
        "No payer promises"
      ]
    },
    {
      "id": "cv_np_decile6_ckd_sglt2_calendar",
      "mode": "sales-simulation",
      "therapeuticArea": "Cardiovascular",
      "persona": "Cardiology NP",
      "title": "Rural HF program with renal concerns",
      "brief": "SGLT2 underused in CKD stage 3 due to misconceptions; no titration calendar.",
      "goals": [
        "Introduce titration calendar with sick-day rules",
        "Track eGFR and UACR at baseline and 12 weeks",
        "Provide CKD-safe counseling guide"
      ],
      "guardrails": [
        "On-label patient education",
        "No outcomes guarantees",
        "No comparative claims"
      ]
    },
    {
      "id": "cv_pa_decile7_postmi_transitions",
      "mode": "sales-simulation",
      "therapeuticArea": "Cardiovascular",
      "persona": "Cardiology PA",
      "title": "Post-MI and HF transitions program",
      "brief": "SGLT2 deferrals to PCP; ARNI starts delayed pending echo; readmissions above benchmark.",
      "goals": [
        "Start SGLT2 before discharge where eligible",
        "Convert to ARNI within 48–72h per protocol",
        "Schedule pharmacy follow-up at day 7"
      ],
      "guardrails": [
        "On-label use",
        "No outcomes guarantees",
        "Respect hospital protocols"
      ]
    },
    {
      "id": "onc_access_time_pressure",
      "mode": "role-play",
      "therapeuticArea": "Oncology",
      "persona": "Oncologist",
      "title": "Oncology | Time-Pressed HCP",
      "brief": "HCP is behind schedule and skeptical about value. You get 60 seconds.",
      "goals": [
        "Gain permission for a later detail",
        "Acknowledge time pressure",
        "Confirm one interest area"
      ],
      "guardrails": [
        "No outcomes claims",
        "No off-label discussion"
      ]
    },
    {
      "id": "prep_adherence_objection",
      "mode": "sales-simulation",
      "therapeuticArea": "HIV",
      "persona": "Internal Medicine MD",
      "title": "HIV PrEP | Adherence concern",
      "brief": "HCP questions adherence support for certain populations.",
      "goals": [
        "Acknowledge concern",
        "Offer label-consistent support resource",
        "Gain agreement on next step"
      ],
      "guardrails": [
        "Stay on-label",
        "No outcomes guarantees"
      ]
    }
  ]
}
